Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing
Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin
Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75